2012 VEITHsymposium: Minimally Invasive Procedures for Aortic Aneurysm Repair
Experts Present New Stenting Techniques Using “Off the Shelf” Devices, Will Combine Good Outcomes...
Read More
Author: PWeekly
2012 VEITHsymposium: Effective Endovascular Treatments of Ruptured Abdominal Aortic Aneurysms
Discussions on the Value and Necessity of Level 1 Evidence The treatment of abdominal aortic...
Read More
2012 VEITHsymposium: Long-Term Patency Rates With SFA Stents
The Particulars: Previous research has not established the success rate for stenting of the...
Read More
2012 VEITHsymposium: Controversial Surgical Treatment for Multiple Sclerosis
Chronic Cerebrovenous Insufficiency Remains a Diagnosis in Question. In 2010, Italian vascular...
Read More
FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease
The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent...
Read More
2012 VEITHsymposium: Simplifying Aortic Arch Repair
The Particulars: Among patients with an inadequate proximal landing zone and/or severe angles...
Read More
2012 VEITHsymposium: Analyzing Hybrid Treatment of Aortic Arch Aneurysms
The Particulars: Hybrid repair of aortic arch aneurysms—in which supra-aortic trunks are rerouted...
Read More
2012 VEITHsymposium: An Alternative for AAA Repair
The Particulars: Alternatives to open surgery for abdominal aortic aneurysms (AAAs) are needed...
Read More
2012 VEITHsymposium: Competing Treatments for Carotid Artery Disease
Exploring Best Medical Treatments vs. an Intervention The continuing debate among vascular...
Read More
2012 VEITHsymposium: Advances in Lower Extremity Arterial Disease
Safety and Outcomes Using New Endovascular Technologies Chronic total obstruction (CTO) of the...
Read More
2012 VEITHsymposium: Comparing Dressing Materials for Donor-Site Wounds
The Particulars: The optimal dressing material for patients with donor-site wounds (DSWs) after...
Read More
2012 VEITHsymposium: Call To Action by Chairman of VEITHsymposium: Treatment of Pulmonary Embolism On The Horizon, Newer Interventions Show Promise
Endovascular treatment of pulmonary embolism, (PE) a relatively new approach built upon a widely...
Read More
2012 VEITHsymposium
New research is being presented at the 2012 VEITHsymposium, the 39th annual symposium on vascular...
Read More
AHA Scientific Sessions 2012: Aspirin Use & Recurrent VTE
The Particulars: Aspirin is commonly prescribed to patients with venous thromboembolism (VTE). The...
Read More
AHA Scientific Sessions 2012: Examining Follow-Up Costs for Angioplasty
The Particulars: In recent years, hospitals have increasingly begun offering angioplasty in house...
Read More
AHA Scientific Sessions 2012: Comparing Revascularization Approaches in Patients With Diabetes & CAD
The Particulars: Few studies have explored outcomes after PCI or CABG among patients with diabetes...
Read More
AHA Scientific Sessions 2012: Can Daily Multivitamins Prevent CVD?
The Particulars: Studies suggest that many patients with cardiovascular disease (CVD) or...
Read More
AHA Scientific Sessions 2012: Experimental Combination Drug Yields Cardiovascular Benefits
The Particulars: Researchers believe that fixed-dose combination therapy for cardiovascular...
Read More
FDA Approves Propel Mini for Chronic Sinusitis
Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and...
Read More
FDA Approves Xeljanz for Rheumatoid Arthritis
The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with...
Read More